about
Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with ThiazolidinedionesAdvanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistanceRegulation of energy balance by inflammation: common theme in physiology and pathologyRegulation of insulin degrading enzyme activity by obesity-associated factors and pioglitazone in liver of diet-induced obese micePersonalized pharmacotherapy in diabetes care using clinical pharmacology data of basal insulin analogues.The characteristics of newly diagnosed adult early-onset diabetes: a population-based cross-sectional studyEndogenous ω-3 polyunsaturated fatty acid production confers resistance to obesity, dyslipidemia, and diabetes in miceMoving on from GWAS: functional studies on the G6PC2 gene implicated in the regulation of fasting blood glucose.The population impact of obesity, sedentary lifestyle, and tobacco and alcohol consumption on the prevalence of type 2 diabetes: Analysis of a health population survey in Chile, 2010.Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress.Immune and Metabolic Regulation Mechanism of Dangguiliuhuang Decoction against Insulin Resistance and Hepatic Steatosis.Antihypertensive drugs and glucose metabolismDiabetes mellitus: The epidemic of the century.Effect of Hypericum perforatum L. extract on insulin resistance and lipid metabolic disorder in high-fat-diet induced obese miceMaintenance of homeostasis in the aging hypothalamus: the central and peripheral roles of succinate.The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesityP65 inactivation in adipocytes and macrophages attenuates adipose inflammatory response in lean but not in obese mice.Metformin attenuates palmitate-induced endoplasmic reticulum stress, serine phosphorylation of IRS-1 and apoptosis in rat insulinoma cellsFumaric acid esters can block pro-inflammatory actions of human CRP and ameliorate metabolic disturbances in transgenic spontaneously hypertensive rats.Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders.Obesity, insulin resistance and comorbidities? Mechanisms of association.Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat DietBeneficial metabolic activities of inflammatory cytokine interleukin 15 in obesity and type 2 diabetes.Diet-Induced Maternal Obesity Alters Insulin Signalling in Male Mice Offspring Rechallenged with a High-Fat Diet in AdulthoodInverse Relationship of the CMKLR1 Relative Expression and Chemerin Serum Levels in Obesity with Dysmetabolic Phenotype and Insulin Resistance.Blood Triglycerides Levels and Dietary Carbohydrate Indices in Healthy Koreans.Novel Role of Endogenous Catalase in Macrophage Polarization in Adipose Tissue.Antidiabetic potential of the heme oxygenase-1 inducer curcumin analogues.Evaluation of fish oil-rich in MUFAs for anti-diabetic and anti-inflammation potential in experimental type 2 diabetic rats.Severely obese adolescents and adults exhibit a different association of circulating levels of adipokines and leukocyte expression of the related receptors with insulin resistance.Prostaglandin E2 receptor EP3 regulates both adipogenesis and lipolysis in mouse white adipose tissue.ROCK1 isoform-specific deletion reveals a role for diet-induced insulin resistanceAir pollution exposure and abnormal glucose tolerance during pregnancy: the project Viva cohort.A post-weaning obesogenic diet exacerbates the detrimental effects of maternal obesity on offspring insulin signaling in adipose tissue.Mitochondria in metabolic disease: getting clues from proteomic studies.Novel approaches to drug discovery for the treatment of type 2 diabetes.Melatonin reduces endoplasmic reticulum stress and autophagy in liver of leptin-deficient mice.Magnesium and disturbances in carbohydrate metabolism.Treatment patterns and clinical characteristics of patients with type 2 diabetes mellitus according to body mass index: findings from an electronic medical records database.Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus
P2860
Q26745533-A4B07C07-B8C3-4D68-A25C-3427E95F0890Q26800114-BA0E8C74-D480-49BC-8AF2-4C60D904B33EQ26829584-27763C3D-E529-4F44-978A-5B6B5F550955Q28537971-A16ECDBF-92F9-437D-B9BE-DB75824CD186Q30809002-C91EC99B-E620-448D-B5DE-CB870D0037A0Q33577817-5BC47A82-E19D-4FEA-B8A9-26C0C36F37A8Q33631964-995B440F-DF1B-465A-8852-7F9533DD1999Q33699177-3632F656-AD7F-4598-85AF-8BBBF16C80C8Q33728455-1F946394-7852-47F3-B9B1-2E8AEE1594E9Q33849720-23D2C361-D968-47F9-8ACA-DAAF99E1522CQ33881724-1AE6801D-A64D-4B0B-BDE5-14EEB525CB99Q33948469-06039448-D1F6-4366-A75D-C674EC5A1032Q34671155-D5698F3A-023E-4767-9BBC-E00517192139Q35004422-551FE6A6-A22C-4B78-82FF-86454CA7D5FFQ35037771-68B75A99-BEE1-4FFA-BE53-E441DC795298Q35142299-F19CCFDE-4FBC-4795-92E4-BE80117A5BFBQ35178548-02B88CF3-6A38-4D62-B8A1-2267DC10409CQ35181450-2E89D765-8235-4B2F-9E4B-70EB5D909D98Q35204440-55C81D66-4297-46B3-8834-57DB783A6BF3Q35438444-F05B5EC5-A7E3-4432-9E4A-6F7100014A6EQ35581288-5B5B4018-141D-4FC0-BFCE-8E07EFF4A23CQ35832166-E85FC83A-BCDE-41AB-BFD9-83AE2B4CD43AQ36025132-B238EB02-D880-422D-8914-C87543F88BC0Q36091550-E6D0C779-A0EC-48DD-B729-7DC5B291FB18Q36893067-96BC5BF9-4154-4F03-9C9F-0B9C9B56736AQ36983411-E3226CBB-27E5-4B27-962B-494F3A00CBD4Q37212642-0267883E-91A3-4D51-9BED-0362623FF619Q37244395-75D10EEB-BE82-4242-A499-BB32CF8A76F8Q37409965-E415E8E3-442F-40C0-9866-D8D286DAA3A7Q37433030-30A6ABDB-BC43-4515-91AB-F18B1C5D12B6Q37529878-B2CFD0A4-A20B-4F1E-ADF9-0C28B3A2F819Q37575422-B2755B5C-73DE-4B7B-9D32-F8439D9A8A5FQ37698775-E90F0238-1D0E-47DE-8FF4-465EF59A53C6Q37719408-2D835444-3C36-452A-8BB0-BDBD81E10647Q38171425-07E507A6-8404-4A43-9756-9700ED324109Q38233063-19107242-9F18-47B4-86C0-8FE1735C2F7FQ38292790-821ABBF1-841E-471D-832C-62210C132BBBQ38479670-D7D69997-7582-498D-AB37-B413C554C7D7Q38650408-2C574D83-0881-4613-A1E5-5A0B10CF9EF5Q38664408-0BB4306D-7065-40D3-818F-7E9CA3BF6937
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mechanisms of insulin resistance in obesity
@ast
Mechanisms of insulin resistance in obesity
@en
Mechanisms of insulin resistance in obesity
@nl
type
label
Mechanisms of insulin resistance in obesity
@ast
Mechanisms of insulin resistance in obesity
@en
Mechanisms of insulin resistance in obesity
@nl
prefLabel
Mechanisms of insulin resistance in obesity
@ast
Mechanisms of insulin resistance in obesity
@en
Mechanisms of insulin resistance in obesity
@nl
P2860
P1476
Mechanisms of insulin resistance in obesity
@en
P2093
Jianping Ye
P2860
P2888
P356
10.1007/S11684-013-0262-6
P577
2013-03-09T00:00:00Z
P5875
P6179
1026797655